PBT fell 55.5% on a 3.3% revenue decline as trading swung to loss

Reported NPAT attributable to the parent fell 19.8% to NZ$8.9m, a 35.7 percentage-point narrower decline than PBT; the analytical pass flags this gap as tax/minority-interest distortion and identifies PBT as the cleaner operating read.

Segment results explain the bulk of the deterioration: Apples earnings fell from NZ$52.1m to NZ$40.6m, and International Trading swung from a NZ$2.3m profit to a NZ$12.4m loss. Net cash from operating activities was broadly flat at NZ$55.4m, but the balance sheet strengthened sharply, with gross borrowings down 57.3% to NZ$43.2m and net debt swinging from NZ$56.5m to a net cash position of NZ$15.8m.

A 3.3% revenue decline produced a 55.5% PBT decline, with PBT margin at 0.7% — Annolyse's historical baseline shows that is still the upper edge of T&G's recent range (4-period mean -1.0%), so the absolute margin level remains thin even after the fall. This matters because the business is operating close to break-even and small further cost or weather shocks can swing the result negative.

The Apples engine softened and International Trading became a drag. Apples revenue fell 2.7% but its segment result fell NZ$11.5m, and International Trading revenue dropped 27.7% while flipping from profit to a NZ$12.4m loss. The release attributes part of this to COVID-driven labour shortages affecting apple sizing and volumes, plus global supply chain disruption — these are external pressures, but they have concentrated earnings risk in the dominant Apples segment (62.4% of revenue).

Leverage moved materially in the company's favour. Gross borrowings fell NZ$57.9m, cash rose NZ$14.3m, and equity grew 10.4% to NZ$573.6m, taking the group into net cash. Total assets at NZ$984.3m sit below Annolyse's historical baseline range (mean NZ$1.1b), consistent with a contracted, more lightly geared balance sheet that gives optionality but also raises questions about reinvestment ambition.

The H1 21 interim shape shows 47.8% of full-year revenue but only 38.5% of full-year NPAT was earned in H1, implying H2 carried disproportionately more profit despite the full-year decline — consistent with the apple harvest cycle, but the second-half profit lift (~NZ$5.5m implied) was modest in absolute terms. Operating cash flow was actually H1-weighted (66.3% in H1), so H2 cash generation of roughly NZ$18.6m was light given peak-season working capital release expectations. The release does not anchor FY22 expectations on labour, freight or pricing, so this result supports neither a clean rebound nor a worsening trajectory.

Pre-lease free cash flow was NZ$6.3m versus NZ$15.1m prior, because capex rose 19.2% to NZ$49.1m (3.6% of revenue, up from 2.9%). FCF-to-NPAT conversion fell to 70.6% from 136.5%, which means the reported earnings were less cash-backed than in the prior year and the headline NPAT decline understates the cash strain. Operating working-capital absorbed NZ$24.5m — within Annolyse's historical baseline range and below the 4-period mean of NZ$69.5m, so the WC build is not abnormal, but it still reduced free cash.

The effective tax rate rose to 38.3% from 24.7%, which would normally amplify the NPAT fall, yet attributable NPAT fell less than PBT. The release does not quantify the offset, but the gap between profit from continuing operations (NZ$13.6m) and attributable NPAT (NZ$8.9m) points to a meaningful minority-interest share. This durability of the reported NPAT is therefore less than the headline suggests; PBT remains the more reliable read.

This briefing cannot assess management's specific FY22 plans for capacity, labour sourcing, or dividend policy, as no forward targets or capital-allocation framework were disclosed in the release.